Short answer · Medically reviewed summary · Last updated: 2026-04-07
The primary medical classification for Homocystinuria, specifically the most common form caused by cystathionine beta-synthase (CBS) deficiency, is ICD-10 code E72.11 and ICD-9 code 270.4. These codes are essential for healthcare providers to accurately document the diagnosis of Homocystinuria for medical records, billing, and research purposes. What is the clinical significance of these diagnostic codes? In the medical community, the coding for Homocystinuria serves as a universal language for clinical documentation.
The primary medical classification for Homocystinuria, specifically the most common form caused by cystathionine beta-synthase (CBS) deficiency, is ICD-10 code E72.11 and ICD-9 code 270.4. These codes are essential for healthcare providers to accurately document the diagnosis of Homocystinuria for medical records, billing, and research purposes.
In the medical community, the coding for Homocystinuria serves as a universal language for clinical documentation. Because Homocystinuria is a complex metabolic disorder that requires lifelong management, accurate coding allows for the tracking of patient outcomes and ensures that insurance and health systems recognize the necessity of specialized care, such as metabolic formula, vitamin B6 supplementation, or methionine-restricted diets. Understanding these codes helps patients and caregivers when discussing coverage for essential treatments with their medical insurance providers.
Homocystinuria is a rare, inherited metabolic disorder characterized by an inability to properly break down the amino acid methionine. This leads to an accumulation of homocysteine in the blood and urine, which can cause significant damage to the connective tissues, cardiovascular system, and central nervous system if left untreated. The condition is inherited in an autosomal recessive pattern, meaning an individual must inherit two copies of the mutated gene—one from each parent—to manifest the disease. For families navigating this diagnosis, the genetic counselor’s role is vital in explaining the 25% recurrence risk for future pregnancies.
The clinical management of Homocystinuria focuses on early detection, often through newborn screening programs, to prevent irreversible complications such as lens dislocation (ectopia lentis), skeletal abnormalities, and thromboembolic events. Because the severity of Homocystinuria can vary significantly between individuals—ranging from vitamin B6-responsive cases to more severe, non-responsive forms—treatment must be highly individualized. Monitoring involves regular blood testing to keep homocysteine levels within a safe, target range.
Navigating a rare diagnosis can be isolating, which is why connecting with others is crucial. Currently, 38 people with Homocystinuria have joined the DiseaseMaps.org community. By sharing lived experiences, members provide invaluable perspectives on managing dietary restrictions and the emotional challenges of living with a chronic metabolic condition. Engaging with this community can help you learn practical strategies for daily life that go beyond clinical literature.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.